| The Influence of Adalimumab on Cardiovascular and Metabolic Risk in Psoriasis (NCT01088165) | Medical University of Vienna | 2010-05-01 |
| Initiation and Titration of Amaryl (NCT01144728) | Sanofi | 2010-05-01 |
| Safety and Effectiveness Study of Insulin Glargine (LANTUS) Initiation and Titration in Patients With Type 2 Diabetes (NCT01127269) | Sanofi | 2010-05-01 |
| Community-Based Participatory Research to Improve Health and Quality of Life of Latino Youth: Every Little Step Counts (NCT01236794) | Arizona State University | 2010-05-01 |
| A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment. (NCT01098539) | GlaxoSmithKline | 2010-05-01 |
| Apelin Levels and G212A Polymorphism of Apelin Receptor (APJ) (NCT01121172) | Aristotle University Of Thessaloniki | 2010-05-01 |
| A Study to Determine the Efficacy and Safety of Albiglutide as Compared With Liraglutide. (NCT01128894) | GlaxoSmithKline | 2010-05-01 |
| A Study of Aleglitazar in Type 2 Diabetes Patients With Moderate Renal Impairment (NCT01043029) | Hoffmann-La Roche | 2010-05-01 |
| Risk Factors for Low Lymphocyte Count in Patients With Type 2 Diabetes (NCT01192659) | AstraZeneca | 2010-05-01 |
| A Study in Participants With Type 2 Diabetes Mellitus (AWARD-3) (NCT01126580) | Eli Lilly and Company | 2010-05-01 |
| Comparison of the Blood Sugar Lowering Effect of Biphasic Insulin Aspart 30 and Insulin Glargine Both Combined With Metformin and Glimepiride in Chinese and Japanese Subjects With Type 2 Diabetes New to Insulin Treatment (NCT01123980) | Novo Nordisk A/S | 2010-05-01 |
| A Study to Investigate the Interaction of GSK1292263 With Rosuvastatin and Simvastatin in Healthy Subjects (NCT01101568) | GlaxoSmithKline | 2010-04-14 |
| Single Dose Study of PF-04991532 in Healthy Subjects (NCT01102673) | Pfizer | 2010-04-01 |
| A Trial Investigating NN1218 in Subjects With Type 1 and Type 2 Diabetes (NCT01121276) | Novo Nordisk A/S | 2010-04-01 |
| Dose Ranging Study of Albiglutide in Japanese Subjects (NCT01098461) | GlaxoSmithKline | 2010-04-01 |
| Impact of Liraglutide on Endothelial Function and Microvascular Blood Flow in Type 2 Diabetes Mellitus (NCT01208012) | ikfe-CRO GmbH | 2010-04-01 |
| Local Measures to Prevent Diabetes in the Værnes Region. (NCT01135901) | Norwegian University of Science and Technology | 2010-04-01 |
| An Efficacy and Safety Study of Fixed-dose Rosiglitazone/Glimepiride to Treat Chinese Type 2 Diabetes Patients (NCT01453049) | GlaxoSmithKline | 2010-04-01 |
| An Evaluation of the Pharmacokinetics of an Oral Contraceptive (Brevicon) When Co-administered With Albiglutide . (NCT01077505) | GlaxoSmithKline | 2010-03-15 |
| A Two Part Trial Investigating the Safety of NN9925 in Healthy Male Subjects (NCT01087645) | Novo Nordisk A/S | 2010-03-12 |
| A Clinical Study to Assess the Safety, Tolerability, and Activity of Oral SRT2104 Capsules Administered for 28 Days to Subjects With Type 2 Diabetes Mellitus (NCT01018017) | GlaxoSmithKline | 2010-03-03 |
| A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus (NCT01071850) | Astellas Pharma Inc | 2010-03-03 |
| The CANTATA-M (CANagliflozin Treatment and Trial Analysis - Monotherapy) Trial (NCT01081834) | Janssen Research & Development, LLC | 2010-03-01 |
| Leukocyte Dysfunction in Diabetic Patients. (NCT01144520) | Sashwati Roy | 2010-03-01 |
| The Effects of Co-admin of Colesevelam and Sitagliptin on Glucose Metabolism in Subjects With Type 2 Diabetes Mellitus (NCT01092663) | KineMed | 2010-03-01 |
| Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus Receiving Background Treatment With Glimepiride Alone or in Combination With Metformin or With Pioglitazone Alone (NCT01089790) | Forest Laboratories | 2010-03-01 |
| Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes (NCT01068665) | Novo Nordisk A/S | 2010-03-01 |
| Effect of Different Insulin Administrations, All in Combination With Metformin, on Glycaemic Control in Subjects With Type 2 Diabetes Inadequately Controlled by Oral Anti-diabetic Drugs (NCT01068652) | Novo Nordisk A/S | 2010-03-01 |
| A Multiple-Ascending Dose Study in Type 2 Diabetes Mellitus Patients (NCT01253278) | Eli Lilly and Company | 2010-03-01 |
| Efficacy and Safety of Linagliptin in Elderly Patients With Type 2 Diabetes (NCT01084005) | Boehringer Ingelheim | 2010-03-01 |
| GAPP 1 Survey: Global Attitudes of Patients and Physicians in Insulin Therapy for Diabetes Mellitus (NCT01950650) | Novo Nordisk A/S | 2010-03-01 |
| Effectiveness of a High-risk Diabetic Patients Program (NCT01051245) | Hospital Italiano de Buenos Aires | 2010-03-01 |
| Web-based Dietary Intervention for Diabetic Patients (NCT01246687) | Monash University | 2010-03-01 |
| A Pharmacokinetic and Pharmacodynamic Study to Determine Blood Levels of JNJ-28431754 (Canagliflozin) in Patients With Type 2 Diabetes Mellitus (NCT01128985) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2010-03-01 |
| An Observational Study Investigating the Safety and Effectiveness of Repaglinide in Chinese Patients (NCT01077570) | Novo Nordisk A/S | 2010-03-01 |
| Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes (NCT01076647) | Novo Nordisk A/S | 2010-03-01 |
| Safety and Efficacy of Linagliptin in Type-2-diabetes Mellitus Patients With Moderate to Severe Renal Impairment (NCT01087502) | Boehringer Ingelheim | 2010-03-01 |
| Effect of Sitagliptin on Postprandial Lipoprotein Metabolism (NCT00939939) | Ludwig-Maximilians - University of Munich | 2010-03-01 |
| Cross-over Study on Effect of Lipid Lowering by Acipimox on Cardiac and Skeletal Muscle Mitochondrial Function (NCT00943059) | Maastricht University Medical Center | 2010-03-01 |
| Study Of Safety And Efficacy Of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes (MK-8835-016) (NCT01059825) | Merck Sharp & Dohme LLC | 2010-02-24 |
| Effects of Once and Twice Daily Dosing Regimen of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes (MK-8835-040) (NCT01054300) | Merck Sharp & Dohme LLC | 2010-02-17 |
| Insulins Glargine and gluLisine strAtegy Versus Premixed Insulin strAteGy: a cOmparative Study (NCT01121835) | Sanofi | 2010-02-01 |
| Technology Intervention for Diabetes Engagement & Self-Care (TIDES) (NCT01440530) | Geisinger Clinic | 2010-02-01 |
| Medium-term Health Coaching and Life-long Monitoring in Diabetes Mellitus (NCT01580098) | Landeskrankenanstalten-Betriebsgesellschaft | 2010-02-01 |
| Investigation of a Switch From Insulin Therapy to a Metformin & Saxagliptin Combination in Patients With Type 2 Diabetes Mellitus (NCT01206647) | ikfe-CRO GmbH | 2010-02-01 |
| A Study in Participants With Type 2 Diabetes Mellitus (NCT01064687) | Eli Lilly and Company | 2010-02-01 |
| Role of Interleukin-6 in Exercise (NCT01073826) | University of Zurich | 2010-02-01 |
| Comparison of NN1250 Versus Insulin Glargine in Subjects With Type 2 Diabetes (NCT01059799) | Novo Nordisk A/S | 2010-02-01 |
| Effects of Hyperglycemia on Myocardial Perfusion in Humans With and Without Type 2 Diabetes (NCT01021865) | Mayo Clinic | 2010-02-01 |
| A Study in Participants With Type 2 Diabetes Mellitus (AWARD-2) (NCT01075282) | Eli Lilly and Company | 2010-02-01 |
| Gut Hormone Profiling in Obese Patients With Type 2 Diabetes (MK-0000-134) (NCT00957957) | Merck Sharp & Dohme LLC | 2010-02-01 |
| Comparison of NN1250 With Insulin Glargine in Subjects With Type 2 Diabetes (NCT01068678) | Novo Nordisk A/S | 2010-02-01 |
| Insulin Glargine for Diabetes Metabolism(DM)Type II Patients Under Enteral Nutrition (NCT01081938) | Sanofi | 2010-02-01 |
| A Pan Asian Trial Comparing Efficacy and Safety of NN5401 and Biphasic Insulin Aspart 30 in Type 2 Diabetes (NCT01059812) | Novo Nordisk A/S | 2010-02-01 |
| A Study of LY2599506 (Oral Agent Medication: Glucokinase Activator 1) in Type 2 Diabetes Mellitus (NCT01029795) | Eli Lilly and Company | 2010-02-01 |
| A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes Mellitus (NCT01042769) | Hoffmann-La Roche | 2010-02-01 |
| Phase II Pharmacodynamic Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney Disease (NCT01053936) | Biogen | 2010-01-31 |
| Action in Diabetes and Vascular Disease Preterax and Diamicron MR Controlled Evaluation Post Trial Observational Study (NCT00949286) | The George Institute | 2010-01-01 |
| Comparison of NN1250 With Sitagliptin in Subjects With Type 2 Diabetes Never Treated With Insulin (NCT01046110) | Novo Nordisk A/S | 2010-01-01 |
| COronary CoLLateralization in Type 2 diabEtic Patients With Chronic Total Occlusion (NCT06054126) | Ruijin Hospital | 2010-01-01 |
| Comparison of NN5401 With Insulin Glargine, Both in Combination With Oral Antidiabetic Drugs, in Subjects With Type 2 Diabetes (NCT01045447) | Novo Nordisk A/S | 2010-01-01 |
| Risk of Hospitalized Infections Among Patients With Type 2 Diabetes Exposed to Oral Antidiabetic Treatment (NCT01086306) | AstraZeneca | 2010-01-01 |
| Better Acceptance of Single Injection Apidra Added to Once Daily Lantus Versus Twice Daily Premixed Insulin in Real Life Use Setting (NCT01079364) | Sanofi | 2010-01-01 |
| Risk of Cardiovascular Events in Patients With Type 2 Diabetes Initiating Oral Antidiabetic Treatments (NCT01086280) | AstraZeneca | 2010-01-01 |
| A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease (NCT01018173) | Hoffmann-La Roche | 2010-01-01 |
| A Study for Patients With Type 2 Diabetes (NCT01027871) | Eli Lilly and Company | 2010-01-01 |
| Pharmacokinetics/Dynamics of Basal (Continuous) Insulin Infusion Administered Either Intradermally or Subcutaneously (NCT01061216) | Becton, Dickinson and Company | 2010-01-01 |
| Observational Study in Japanese Type 2 Diabetes Patients (NCT01055808) | Eli Lilly and Company | 2010-01-01 |
| Pharmaceutical Care in Type 2 Diabetes (NCT01298726) | Universidade Federal de Ouro Preto | 2010-01-01 |
| Comparison of NN5401 Versus Insulin Glargine, Both Combined With Metformin Treatment, in Subjects With Type 2 Diabetes (NCT01045707) | Novo Nordisk A/S | 2010-01-01 |
| Risk of Acute Liver Failure Among Patients With Type 2 Diabetes Exposed to Oral Antidiabetic Treatments (NCT01086293) | AstraZeneca | 2010-01-01 |
| The Effect of NN1250 in Subjects With Type 2 Diabetes of Different Race and/or Ethnic Origin (NCT01043510) | Novo Nordisk A/S | 2010-01-01 |
| A Study to Compare Taspoglutide and Insulin Glargine in Insulin-Naïve Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin and Sulfonylurea Combination Therapy (NCT01051011) | Hoffmann-La Roche | 2010-01-01 |
| A Two Part Trial Investigating the Safety of NN9924 in Healthy Male Subjects (NCT01037582) | Novo Nordisk A/S | 2009-12-17 |
| CANVAS - CANagliflozin cardioVascular Assessment Study (NCT01032629) | Janssen Research & Development, LLC | 2009-12-09 |
| A Clinical Study to Assess the Safety and Pharmacokinetics of SRT2379 in Normal Healthy Male Volunteers (NCT01018628) | GlaxoSmithKline | 2009-12-07 |
| A Study of LY2599506 in Patients With Type 2 Diabetes (NCT01024244) | Eli Lilly and Company | 2009-12-01 |
| Prescription Patterns, Resource Utilization & Costs - Add-on Therapy With Anti Dipeptidyl Peptidase-IVs vs Rosiglitazone (NCT01332370) | GlaxoSmithKline | 2009-12-01 |
| Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes Mellitus (NCT01007097) | Takeda | 2009-12-01 |
| Self-Management and Resourceful Transition of Type 2 Diabetes With Stage 3 Kidney Disease (NCT01067963) | University of Colorado, Denver | 2009-12-01 |
| Quitting Caffeine for Better Glucose Metabolism (NCT01030796) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2009-12-01 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Doses of JNJ-38431055, Sitagliptin, and Co-administration of JNJ-38431055 and Sitagliptin (NCT01054118) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2009-12-01 |
| Examining Genetic Influence on Response to Beta-Blocker Medications in People With Type 2 Diabetes (NCT00925119) | University of Maryland, Baltimore | 2009-12-01 |
| Safety & Effectiveness on Vascular Structure and Function of ACZ885 in Atherosclerosis and Either T2DM or IGT Patients (NCT00995930) | Novartis Pharmaceuticals | 2009-12-01 |
| Safety and Efficacy Study of EGT0001442 in Subjects With Type 2 Diabetes Mellitus (NCT01029704) | Theracos | 2009-12-01 |
| Four-Hour Evaluation of a Medical Food in Subjects With Type 2 Diabetes (NCT01188200) | Abbott Nutrition | 2009-12-01 |
| Effects of Nateglinide on Postprandial Glucose Excursion by Restoring Early Phase Insulin Secretion (NCT01030952) | Novartis Pharmaceuticals | 2009-12-01 |
| A Study of Single Doses of RO4998452 in Patients With Type 2 Diabetes (NCT01044017) | Hoffmann-La Roche | 2009-12-01 |
| Modulating the Stress Response in Diabetes Mellitus Type 2 Patients Undergoing Colon Surgery (NCT02863276) | University Hospital, Basel, Switzerland | 2009-12-01 |
| A Study With RO5095932 in Patients With Type 2 Diabetes on Stable Metformin Therapy. (NCT01017302) | Hoffmann-La Roche | 2009-12-01 |
| The Effects of Lipoic Acid on Glycaemic Control in Type 2 Diabetes (NCT00398892) | University of Edinburgh | 2009-12-01 |
| Avandamet Bioequivalence Study Brazil - Fed Administration (NCT01332071) | GlaxoSmithKline | 2009-11-24 |
| A Study in Type 2 Diabetic Subjects on Stable Metformin Therapy to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Co-administering Single and Multiple Oral Doses of GSK1292263 (NCT01128621) | GlaxoSmithKline | 2009-11-23 |
| Comparison of NN5401 With Biphasic Insulin Aspart 30 in Type 2 Diabetes (NCT01009580) | Novo Nordisk A/S | 2009-11-05 |
| Efficacy and Safety of BI 10773 in Combination With Insulin in Patients With Type 2 Diabetes (NCT01011868) | Boehringer Ingelheim | 2009-11-01 |
| Comparison of NN1250 With Insulin Glargine in Type 2 Diabetes (NCT01006291) | Novo Nordisk A/S | 2009-11-01 |
| Efficacy and Safety of Alogliptin Plus Metformin in Patients With Type 2 Diabetes (NCT01023581) | Takeda | 2009-11-01 |
| Safety of Liraglutide in Pediatric Patients With Type 2 Diabetes (NCT00943501) | Novo Nordisk A/S | 2009-11-01 |
| A Two Part Trial Investigating NN1952 in Healthy Subjects and Subjects With Type 1 and Type 2 Diabetes (NCT01028404) | Novo Nordisk A/S | 2009-11-01 |
| Association of AGTR1 and ACACB Gene Polymorphism and Diabetic Nephropathy in Type 2 Diabetes (NCT01069549) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2009-11-01 |